Literature DB >> 23698531

Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010.

Julien Loubinoux1, Céline Plainvert, Gislène Collobert, Gérald Touak, Anne Bouvet, Claire Poyart.   

Abstract

We characterized 182 Streptococcus dysgalactiae subsp. equisimilis isolates and analyzed the epidemiological data on the corresponding infections. stG6, stG485, and stG6792 were the 3 most prevalent invasive emm types among the 27 different emm types recovered. High rates of antimicrobial resistance were observed for macrolides (26.4%) and tetracycline (34.6%).

Entities:  

Mesh：

Year:  2013        PMID： 23698531      PMCID： PMC3719644          DOI： 10.1128/JCM.01262-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  33 in total

1.  Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.

Authors:  Jun Sawai; Tadao Hasegawa; Takuya Kamimura; Akira Okamoto; Daisuke Ohmori; Nobuyuki Nosaka; Keiko Yamada; Keizo Torii; Michio Ohta
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

2.  Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen.

Authors:  Daisuke Tanaka; Junko Isobe; Masanori Watahiki; Yoshiyuki Nagai; Chihiro Katsukawa; Ryuji Kawahara; Miyoko Endoh; Rumi Okuno; Nanako Kumagai; Masakado Matsumoto; Yoshiro Morikawa; Tadayoshi Ikebe; Haruo Watanabe
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

3.  Identification of a receptor required for the anti-inflammatory activity of IVIG.

Authors:  Robert M Anthony; Fredrik Wermeling; Mikael C I Karlsson; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-26       Impact factor: 11.205

4.  Distribution of emm types and genetic characterization of the mgc locus in group G Streptococcus dysgalactiae subsp. equisimilis from a hospital in northern Taiwan.

Authors:  Sung-Pin Tseng; Yu-Yin Lin; Jui-Chang Tsai; Po-Ren Hsueh; Hsiao-Jan Chen; Wei-Chun Hung; Lee-Jene Teng
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

5.  Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B.

Authors:  Laura N Broyles; Chris Van Beneden; Bernard Beall; Richard Facklam; P Lynn Shewmaker; Paul Malpiedi; Pamala Daily; Arthur Reingold; Monica M Farley
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

6.  Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination.

Authors:  David J McMillan; Debra E Bessen; Marcos Pinho; Candace Ford; Gerod S Hall; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

7.  Human infections due to Streptococcus dysgalactiae subspecies equisimilis.

Authors:  Claudia M Brandt; Barbara Spellerberg
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

8.  Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections.

Authors:  T Takahashi; K Sunaoshi; K Sunakawa; S Fujishima; H Watanabe; K Ubukata
Journal:  Clin Microbiol Infect       Date:  2009-09-02       Impact factor: 8.067

9.  Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections.

Authors:  Katsuhiko Sunaoshi; Somay Y Murayama; Keiko Adachi; Michiko Yagoshi; Katsuko Okuzumi; Naoko Chiba; Miyuki Morozumi; Kimiko Ubukata
Journal:  J Med Microbiol       Date:  2010-01       Impact factor: 2.472

10.  Streptococcus dysgalactiae subsp. equisimilis Bacteremia, Finland, 1995-2004.

Authors:  Sari Rantala; Susanna Vahakuopus; Jaana Vuopio-Varkila; Risto Vuento; Jaana Syrjanen
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883
View more
  15 in total

Review 1.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

2.  Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.

Authors:  Dara L Horn; Emma A Roberts; Jolie Shen; Jeannie D Chan; Eileen M Bulger; Noel S Weiss; John B Lynch; Chloe Bryson-Cahn; Bryce R H Robinson
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

3.  Point-Counterpoint: A Nucleic Acid Amplification Test for Streptococcus pyogenes Should Replace Antigen Detection and Culture for Detection of Bacterial Pharyngitis.

Authors:  Bobbi S Pritt; Robin Patel; Thomas J Kirn; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2016-07-20       Impact factor: 5.948

4.  Beta-hemolytic Streptococcus dysgalactiae strains isolated from horses are a genetically distinct population within the Streptococcus dysgalactiae taxon.

Authors:  Marcos D Pinho; Erdal Erol; Bruno Ribeiro-Gonçalves; Catarina I Mendes; João A Carriço; Sandra C Matos; Silvia Preziuso; Antina Luebke-Becker; Lothar H Wieler; Jose Melo-Cristino; Mario Ramirez
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

5.  Molecular Epidemiological Features and Antibiotic Susceptibility Patterns of Streptococcus dysgalactiae subsp. equisimilis Isolates from Korea and Japan.

Authors:  Sunjoo Kim; Jung Hyun Byun; Hyunwoong Park; Jaehyeon Lee; Hye Soo Lee; Haruno Yoshida; Akiyoshi Shibayama; Tomohiro Fujita; Yuzo Tsuyuki; Takashi Takahashi
Journal:  Ann Lab Med       Date:  2018-05       Impact factor: 3.464

6.  Etiology of Cellulitis and Clinical Prediction of Streptococcal Disease: A Prospective Study.

Authors:  Trond Bruun; Oddvar Oppegaard; Bård R Kittang; Haima Mylvaganam; Nina Langeland; Steinar Skrede
Journal:  Open Forum Infect Dis       Date:  2015-11-25       Impact factor: 3.835

7.  Molecular Characterization of Invasive Streptococcus dysgalactiae subsp. equisimilis, Japan.

Authors:  Takeaki Wajima; Miyuki Morozumi; Shigeo Hanada; Katsuhiko Sunaoshi; Naoko Chiba; Satoshi Iwata; Kimiko Ubukata
Journal:  Emerg Infect Dis       Date:  2016-02       Impact factor: 6.883

8.  Group G streptococcal myositis in a patient with myeloproliferative neoplasm.

Authors:  Monica Midha; Marnie E Rosenthal
Journal:  IDCases       Date:  2016-07-25

9.  Pathogenicity Induced by Invasive Infection of Streptococcus dysgalactiae subsp. equisimilis in a Mouse Model of Diabetes.

Authors:  Kohei Ogura; Kayo Okumura; Yukiko Shimizu; Teruo Kirikae; Tohru Miyoshi-Akiyama
Journal:  Front Microbiol       Date:  2018-09-21       Impact factor: 5.640

10.  Molecular subtyping and antimicrobial susceptibility of Streptococcus dysgalactiae subspecies equisimilis isolates from clinically diseased pigs.

Authors:  Sang Ik Oh; Jong Wan Kim; Jongho Kim; Byungjae So; Bumseok Kim; Ha Young Kim
Journal:  J Vet Sci       Date:  2020-07       Impact factor: 1.672
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.